NIOX Group Future Growth
Future criteria checks 1/6
NIOX Group's earnings is forecasted to decline at -2.9% per annum while its annual revenue is expected to grow at 13.9% per year. EPS is expected to decline by 5.1%. Return on equity is forecast to be 11.4% in 3 years.
Key information
-2.9%
Earnings growth rate
-5.1%
EPS growth rate
Biotechs earnings growth | 49.4% |
Revenue growth rate | 13.9% |
Future return on equity | 11.4% |
Analyst coverage | Low |
Last updated | 24 May 2023 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2025 | 48 | 12 | 13 | 15 | 3 |
12/31/2024 | 42 | 9 | 12 | 12 | 3 |
12/31/2023 | 37 | 7 | 8 | 8 | 3 |
12/31/2019 | 35 | -17 | -35 | -25 | N/A |
9/30/2019 | 37 | -24 | -48 | -38 | N/A |
6/30/2019 | 39 | -32 | -61 | -51 | N/A |
3/31/2019 | 43 | -39 | -51 | -46 | N/A |
12/31/2018 | 48 | -47 | -41 | -41 | N/A |
9/30/2018 | 52 | -50 | -36 | -36 | N/A |
6/30/2018 | 56 | -53 | -31 | -31 | N/A |
3/31/2018 | 51 | -57 | -45 | -44 | N/A |
12/31/2017 | 46 | -60 | -58 | -58 | N/A |
6/30/2017 | 30 | -53 | -54 | -54 | N/A |
3/31/2017 | 27 | -45 | -56 | -55 | N/A |
12/31/2016 | 23 | -37 | -57 | -57 | N/A |
9/30/2016 | 22 | -46 | N/A | -63 | N/A |
6/30/2016 | 21 | -42 | N/A | -69 | N/A |
3/31/2016 | 16 | -46 | N/A | -62 | N/A |
12/31/2015 | 11 | -50 | N/A | -56 | N/A |
9/30/2015 | 6 | -45 | N/A | -48 | N/A |
6/30/2015 | 1 | -40 | N/A | -40 | N/A |
3/31/2015 | 0 | -38 | N/A | -38 | N/A |
12/31/2014 | N/A | -35 | N/A | -37 | N/A |
9/30/2014 | N/A | -32 | N/A | -33 | N/A |
6/30/2014 | N/A | -29 | N/A | -30 | N/A |
3/31/2014 | N/A | -24 | N/A | -24 | N/A |
12/31/2013 | N/A | -20 | N/A | -18 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 82C's earnings are forecast to decline over the next 3 years (-2.9% per year).
Earnings vs Market: 82C's earnings are forecast to decline over the next 3 years (-2.9% per year).
High Growth Earnings: 82C's earnings are forecast to decline over the next 3 years.
Revenue vs Market: 82C's revenue (13.9% per year) is forecast to grow faster than the German market (4.3% per year).
High Growth Revenue: 82C's revenue (13.9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 82C's Return on Equity is forecast to be low in 3 years time (11.4%).